Skip to main content
. 2009 Feb 17;27(10):1637–1643. doi: 10.1200/JCO.2008.18.1701

Table 2.

Response by Treatment Regimen

Treatment Regimen No. of Patients % of Patients
CR nPR PR NR
Fludarabine-based 113 30 27 27 13
FC/FM 137 34 27 23 11
FCR 345 70 10 14 3
Overall 595 54 17 18 7

Abbreviations: CR, complete remission; nPR, nodular partial remission; PR, partial remission; NR, no response; FC, fludarabine with cyclophosphamide; FM, fludarabine with mitoxantrone; FCR, fludarabine, cyclophosphamide, and rituximab.